Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

771 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Temporal Trends in Clinical and Pathological Characteristics for Men Undergoing Radical Prostatectomy Between 1995 and 2013 at Rigshospitalet, Copenhagen, Denmark, and Stanford University Hospital, United States.
Loft MD, Berg KD, Kjaer A, Iversen P, Ferrari M, Zhang CA, Brasso K, Brooks JD, Røder MA. Loft MD, et al. Among authors: kjaer a. Clin Genitourin Cancer. 2017 Sep 6:S1558-7673(17)30269-0. doi: 10.1016/j.clgc.2017.08.014. Online ahead of print. Clin Genitourin Cancer. 2017. PMID: 28988695
First-in-human uPAR PET: Imaging of Cancer Aggressiveness.
Persson M, Skovgaard D, Brandt-Larsen M, Christensen C, Madsen J, Nielsen CH, Thurison T, Klausen TL, Holm S, Loft A, Berthelsen AK, Ploug M, Pappot H, Brasso K, Kroman N, Højgaard L, Kjaer A. Persson M, et al. Among authors: kjaer a. Theranostics. 2015 Sep 13;5(12):1303-16. doi: 10.7150/thno.12956. eCollection 2015. Theranostics. 2015. PMID: 26516369 Free PMC article. Clinical Trial.
Safety, Dosimetry, and Tumor Detection Ability of 68Ga-NOTA-AE105: First-in-Human Study of a Novel Radioligand for uPAR PET Imaging.
Skovgaard D, Persson M, Brandt-Larsen M, Christensen C, Madsen J, Klausen TL, Holm S, Andersen FL, Loft A, Berthelsen AK, Pappot H, Brasso K, Kroman N, Højgaard L, Kjaer A. Skovgaard D, et al. Among authors: kjaer a. J Nucl Med. 2017 Mar;58(3):379-386. doi: 10.2967/jnumed.116.178970. Epub 2016 Sep 8. J Nucl Med. 2017. PMID: 27609788 Free article.
64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours After Injection.
Loft M, Carlsen EA, Johnbeck CB, Johannesen HH, Binderup T, Pfeifer A, Mortensen J, Oturai P, Loft A, Berthelsen AK, Langer SW, Knigge U, Kjaer A. Loft M, et al. Among authors: kjaer a. J Nucl Med. 2021 Jan;62(1):73-80. doi: 10.2967/jnumed.120.244509. Epub 2020 May 22. J Nucl Med. 2021. PMID: 32444370 Free article. Clinical Trial.
Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial.
Fosbøl MØ, Kurbegovic S, Johannesen HH, Røder MA, Hansen AE, Mortensen J, Loft A, Petersen PM, Madsen J, Brasso K, Kjaer A. Fosbøl MØ, et al. Among authors: kjaer a. J Nucl Med. 2021 Mar;62(3):354-359. doi: 10.2967/jnumed.120.248120. Epub 2020 Aug 6. J Nucl Med. 2021. PMID: 32764119 Free PMC article. Clinical Trial.
Semiautomatic Tumor Delineation for Evaluation of 64Cu-DOTATATE PET/CT in Patients with Neuroendocrine Neoplasms: Prognostication Based on Lowest Lesion Uptake and Total Tumor Volume.
Carlsen EA, Johnbeck CB, Loft M, Pfeifer A, Oturai P, Langer SW, Knigge U, Ladefoged CN, Kjaer A. Carlsen EA, et al. Among authors: kjaer a. J Nucl Med. 2021 Nov;62(11):1564-1570. doi: 10.2967/jnumed.120.258392. Epub 2021 Feb 26. J Nucl Med. 2021. PMID: 33637589 Free PMC article.
771 results